Efficacy of Tecar Device With Exercises in Ankle Sprain
Launched by CAIRO UNIVERSITY · Apr 11, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a treatment called TECAR therapy when combined with specific exercises for people who have suffered an acute ankle sprain. The aim is to see if this combination can help reduce pain, improve balance, enhance body awareness (called proprioception), and make daily activities easier for patients. Participants will be divided into two groups: one group will receive standard physical therapy exercises, while the other group will also receive TECAR therapy during these exercises. The treatment will last for four weeks, with two sessions each week.
To be eligible for this trial, participants need to be between 20 and 40 years old and have a specific type of ankle sprain that is diagnosed by an orthopedic surgeon. They must also have a body mass index (BMI) of 30 or lower. However, individuals with fractures, certain medical conditions, or who are pregnant cannot participate. Overall, this study aims to provide valuable insights into whether TECAR therapy can improve recovery outcomes for people with ankle sprains.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Gender will be male and female.
- • Age from 20-40 years old.
- • Grade \| and \|\| lateral ankle sprain.
- • Patients who will be diagnosed and referred by orthopedic surgeon.
- • acute stage of lateral ankle sprain.
- • BMI ≤ 30.
- • Positive confirming tests.
- Exclusion Criteria:
- • Ankle fractures such as talus bone fracture, tibia fracture, ankle dislocation.
- • Unwilling to continue treatment.
- • Contraindications to use TECAR therapy, such as pregnancy, the presence of malignant tissue, tumors, in the ankle, and electrical devices implanted in the body.
- • Grade \|\|\| ankle sprain.
- • Systematic diseases such as rheumatoid arthritis.
- • Recently received intra-steroid injection
- • Pain exacerbation during the intervention.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported